Fresh Drug Launches Scheduled for Approval in 2024

Understanding “Novel” Drugs

“Novel” drugs refer to medications that have not previously received approval for marketing within the United States. For comprehensive details regarding all of the FDA’s approved drugs and biological products, you may refer to the Drugs@FDA resource.

FDA Approvals of Novel Drug Therapies for 2024

The following table serves as an ongoing record of the novel drug approvals made by the FDA’s Center for Drug Evaluation and Research (CDER) in 2024.

*The term “FDA-approved use” featured on this platform is intended for illustrative purposes only. To find the FDA-sanctioned uses including indications, target populations, and dosing regimens for each listed product, please check the latest approved Prescribing Information (accessible by clicking on the Drug Name).